0161 850 2491
SkinViva Training Manchester

BELKYRA® (Kybella) Fat Reduction Injections

dr tim pearce founder

NEW Course for 2018

BELKYRA® (Kybella) Fat Reduction Injections

BELKYRA® is a new injectable from Allergan, the makers of BOTOX®, which is expected to be available in the UK from Spring 2018.

BELKYRA® (known as Kybella in the USA, where it is already available) is a treatment designed to treat submental fat – or double chin – to create a slimmer and more distinct profile. The injections are described as ‘fat-melting’ or ‘fat busting’ as they literally work to break down fatty deposits, which are then expelled by the body’s own processes.

The product is set to revolutionise the cosmetic treatments market and is eagerly awaited by a growing number of clients who have read or heard about it.

  • Surveys have shown that 67% of patients hate the double chin area
  • BELKYRA® can be used to improve and accentuate the chin and jawline area
  • Ideal for women who want to get rid of a double chin for a slimmer, more feminine profile
  • Equally, the treatment will interest men who desire a sharper, more masculine jawline

While BELKYRA® is in some ways a similar treatment to Aqualyx, in that it gets rid of fatty deposits, it is expected to offer superior results and with fewer side effects.

Availability of BELKYRA® in the UK is pending MHRA approvals and we are unable to offer any course dates until it is available, but we have been reassured that it will be during 2018. We expect that the product will only be licensed for certain medical professionals and will issue more information on this when we are able to.

As we work very closely with Allergan, SkinViva Training expect to be among the first to receive product and offer training for practitioners in the UK.

We are inviting anyone interested in BELKYRA® training to register interest now in order to be the first to hear about product and training availability.

Register Your Interest

Subscribe to our BELKYRA® Training Mailing List

* indicates required

What others say about this post? (20 Comments)

Leave a Comment

Your email address will not be published. Required fields are marked *